The news is by your side.

Highlights

National News

Africa

Economy

Politics

Security

Sports

World

Health

South Africa: 11 Women Found Dead in Ekurhuleni in 10 Weeks

By Halimatu Abdulkadiri South African police have confirmed the discovery of another woman’s body in the Ekurhuleni municipality, east of Johannesburg, bringing the number of women found dead in the area over the past 10 weeks to 11. Police said the latest body was discovered around midday on Sunday in an open area after a security company vehicle patrolling the vicinity spotted it and alerted authorities. Police spokesperson, Brigadier Brenda Muridili, confirmed the discovery but said the identity, age and cause of…

Ebola Races Ahead: UN Warns of Deadly Gap as DRC Death Toll Nears 3,000

The world is facing a renewed Ebola emergency in the Democratic Republic of the Congo (DRC), with the United Nations warning that the virus is spreading faster than efforts to contain it as the death toll approaches the grim milestone of 3,000. The warning has renewed concerns over the capacity of national authorities and international humanitarian agencies to keep pace with an outbreak that is rapidly expanding across affected communities, particularly in provinces already grappling with insecurity, weak infrastructure…

Uganda Declares End to Ebola Outbreak After 42 Days Without New Cases

Uganda has officially declared an end to its latest Ebola outbreak after recording 42 consecutive days without a new confirmed case. The declaration was announced on Thursday, August 27, 2026, in joint statements by the World Health Organisation (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC). The outbreak, caused by the Bundibugyo strain of the Ebola virus, was declared on May 15, 2026. Uganda recorded 20 confirmed cases, including 15 imported from the Democratic Republic of the Congo…

Can Cuba’s New 2C12 Drug Transform Cancer Care? Human Trials Begin

Cuba advances home-grown cancer drug as 2C12 enters human trials Cuban scientists have reached a potentially significant milestone in the country’s long-running effort to develop home-grown cancer treatments, with an experimental drug known as 2C12 ready to enter clinical testing in patients suffering from advanced melanoma. The candidate was developed by researchers at Cuba’s Center for Molecular Immunology (CIM) and is designed around an approach similar to that used by pembrolizumab, an established immune-checkpoint…

Recent Posts

exclusive Videos

Gists

Editor's Picks

Politics

Economy

world

Africa